PJ-375 Nanoparticle-Mediated Intracellular Delivery of Imatinib, a PDGF-Receptor Tyrosine Kinase Inhibitor, in Porcine Coronary Arteries from Nanoparticle-Eluting Stent Attenuates Neointimal Formation(Restenosis basic/clinical(04)(IHD),Poster Session(Japa

スポンサーリンク

概要

• 論文の詳細を見る
• 社団法人日本循環器学会の論文
• 2008-03-01

著者

• Egashira Kensuke

  Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University

• Hara Kaori

  HOSOKAWA Powder Technology Research Institute

• Tsujimoto Hiroyuki

  HOSOKAWA Powder Technology Research Institute

• Sunagawa Kenji

  Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University

• 江頭 健輔

  九州大院・医・循環器内科学

• 江頭 健輔

  九州大

• 江頭 健輔

  九州大学循環器内科学

• 江頭 健輔

  九州大学医学部循環器内科

• Tukie Noriaki

  Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University

• Sunagawa Kenji

  Department Of Cardiovascular Medicine Graduate School Of Medical Sciences Kyushu University

• Iwata Eiko

  Department Of Cardiovascular Medicine Kyushu University

• Masuda Seigo

  Department of Cardiovascular Medicine, Kyushu University

• Nakano Kaku

  Department of Cardiovascular Medicine, Kyushu University

• Eshima Kenichi

  九州大学 循環器内科学

• Nakano Kaku

  Department Of Cardiovascular Medicine Kyushu University

• Masuda Seigo

  Department Of Cardiovascular Medicine Kyushu University

• Tukie Noriaki

  Department Of Cardiovascular Medicine Kyushu University

• Sunagawa Kenji

  Department Of Cardiovascular Medicine Kyushu University

• Egashira Kensuke

  Department Of Cardiovascular Medicine Graduate School Of Medical Sciences Kyushu University

• Sunagawa Kenji

  Department Of Cardiovascular Dynamics National Cardiovascular Center

• 江頭 健輔

  九州大学大学院医学研究院

• Egashira Kensuke

  The Research Institute Of Angiocardiology And Cardiovascular Clinic Kyushu University

• Egashira Kensuke

  Research Institute Of Angiocardiology And Cardiovascular Clinic Kyushu University Faculty Of Medicin

• Egashira Kensuke

  The Department Of Cardiovascular Medicine Department Of Medicine And Bioregulatory Science

• Tsujimoto Hiroyuki

  Hosokawa Micron Corporation, 1-9 Shoudai, Tajika, Hirakata, Osaka 573-1132, Japan

• Hara Kaori

  Hosokawa Micron Corporation, 1-9 Shoudai, Tajika, Hirakata, Osaka 573-1132, Japan

• Sunagawa Kenji

  Department of Advanced Therapeutics for Cardiovascular Diseases, Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences

関連論文

• OJ-212 Nanoparticle-Mediated Intracellular Delivery of Pitavastatin to Endothelial Progenitor Cells Ex Vivo Recovers the Functional Activity for Therapeutic Neovascularization(OJ36,Peripheral Circulation/Vascular Disease (Therapy) 2 (H),Oral Presentation
• FRS-016 Nanoparticle-Mediated Endothelial Cell-Selective Delivery of Pitavastatin Induces Functional Collateral Arteries (Therapeutic Arteriogenesis) in a Rabbit Model of Chronic Hindlimb Ischemia(FRS4,Topics in Peripheral Arterial Disease (H),Featured Re
• Diagnostic Value of the Recovery Time-Course of ST Slope on Exercise ECG in Discriminating False-From True-Positive ST-Segment Depressions
• PJ-336 Pitavastatin Incorporated Nanoparticle-Eluting Stent Attenuates In-Stent Stenosis, and Prevents Adverse Effects of Silorimus-Eluting Cypher Stent in Porcine Coronary Artery Model(PJ057,Translational Science (Cardiac) (H),Poster Session (Japanese),T
• FRS-066 When and How should We Use Central BP in Clinical Hypertension? : Report from ABC-J Study(FRS14,New Aspects for Hypertension (H),Featured Research Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• OE-145 Multi-center Cross-sectional Study to Characterize Antihypertensive Treatments in terms of Central Blood Pressure Evaluated by Radial Artery Pulse Waveform(Hypertension, clinical(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting
• Servo-Controlled Hind-Limb Electrical Stimulation for Short-Term Arterial Pressure Control
• PE-467 Donepezil, Acetylcholinesterase Inhibitor, Prevents Progression of Ventricular Remodeling and Dysfunction in Rats after Myocardial Infarction(Heart failure, basic-3 (M) PE78,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of
• 5 Artificial Bioregulation "Exceeding that by Brain" Enables Novel Treatment Strategy for Cardiovascular Diseases("State of the Art" Biomedical Technology Developed in Japan Will Inspire Intricate Applications in Cardiology in the 21st Century,Roundtable
• 2 Development of Autopilot System for Cardiac Care("State of the Art" Biomedical Technology Developed in Japan Will Inspire Intricate Applications in Cardiology in the 21st Century,Roundtable Discussion 7 (RT7) (I),The 70th Anniversary Annual Scientific M
• Aortic Depressor Nerve Stimulation Markedly Improves the Survival Rate after Acute Myocardial Infarction in Rats (Acute Myocardial Infarction, Basic 5 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Ischemia Induced Conduction Delay Plays a Key Role in Predisposing the Heart to Ventricular Fibrillation (Arrhythmia, Basic 5 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Estimation of Preload Recruitable Stroke Work Relationship from Steady-state Hemodynamics Without Recording Ventricular Pressure-volume Relationship(Cardiac Function, Basic/Clinical 1 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Soc
• Acute Myocardial Ischemia Causes Local Glutamate Release via Retrograde Transport of Glutamate Transporters(Metabolism/Biochemistry/Energetics 1 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Intravascular Parasympathetic Cardiac Nerve Stimulation prevents Ventricular Arrhythmias during Acute Coronary Ischemia(Acute Myocardial Infarction, Clinical (Pathophysiology) 2 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society
• Chronic Vagal Stimulation Decreased Vasopressin Secretion and Sodium Ingestion in Heart Failure Rats after Myocardial Infarction(Heart Failure, Basic 2 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Effects of Abdominal Vagal Nerve Activation on Hemodynamics of Acute Myocardial Infarction(Autonomic Nervous System 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Steep Repolarization Gradient in the Epicardium Develops Phase-2 Reentry and Subsequent Ventricular Tachyarrhythmias in a Model of the Brugada Syndrome(Arrhythmia, Basic 3 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• PJ-504 Sodium Channel Block with Pilsicainide Accentuates the Arrhythmogenic Substrate in a Model of the Brugada Syndrome(Arrhythmia, Basic 6 (A) : PJ84)(Poster Session (Japanese))
• PJ-494 High Resolution Optical Mapping of Cardiac Action Potentials in Freely Beating Rabbit Hearts(Arrhythmia, Basic 5 (A) : PJ83)(Poster Session (Japanese))
• Angiotensin II Type 1 Receptor Blocker Attenuates Myocardial Remodeling and Preserves Diastolic Function in Diabetic Heart
• PE-467 Donepezil, Acetylcholinesterase Inhibitor, Prevents Progression of Ventricular Remodeling and Dysfunction in Rats after Myocardial Infarction(Heart failure, basic-3 (M) PE78,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of
• 5 Artificial Bioregulation "Exceeding that by Brain" Enables Novel Treatment Strategy for Cardiovascular Diseases("State of the Art" Biomedical Technology Developed in Japan Will Inspire Intricate Applications in Cardiology in the 21st Century,Roundtable
• 2 Development of Autopilot System for Cardiac Care("State of the Art" Biomedical Technology Developed in Japan Will Inspire Intricate Applications in Cardiology in the 21st Century,Roundtable Discussion 7 (RT7) (I),The 70th Anniversary Annual Scientific M
• Estimation of Preload Recruitable Stroke Work Relationship from Steady-state Hemodynamics Without Recording Ventricular Pressure-volume Relationship(Cardiac Function, Basic/Clinical 1 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Soc
• Intravascular Parasympathetic Cardiac Nerve Stimulation prevents Ventricular Arrhythmias during Acute Coronary Ischemia(Acute Myocardial Infarction, Clinical (Pathophysiology) 2 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society
• Pulmonary Capillary Hemangiomatosis With Severe Pulmonary Hypertension
• PE-467 Donepezil, Acetylcholinesterase Inhibitor, Prevents Progression of Ventricular Remodeling and Dysfunction in Rats after Myocardial Infarction(Heart failure, basic-3 (M) PE78,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of
• 5 Artificial Bioregulation "Exceeding that by Brain" Enables Novel Treatment Strategy for Cardiovascular Diseases("State of the Art" Biomedical Technology Developed in Japan Will Inspire Intricate Applications in Cardiology in the 21st Century,Roundtable
• 2 Development of Autopilot System for Cardiac Care("State of the Art" Biomedical Technology Developed in Japan Will Inspire Intricate Applications in Cardiology in the 21st Century,Roundtable Discussion 7 (RT7) (I),The 70th Anniversary Annual Scientific M
• Estimation of Preload Recruitable Stroke Work Relationship from Steady-state Hemodynamics Without Recording Ventricular Pressure-volume Relationship(Cardiac Function, Basic/Clinical 1 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Soc
• Intravascular Parasympathetic Cardiac Nerve Stimulation prevents Ventricular Arrhythmias during Acute Coronary Ischemia(Acute Myocardial Infarction, Clinical (Pathophysiology) 2 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society
• Dynamic Characteristics of Carotid Sinus Pressure-Nerve Activity Transduction in Rabbits
• FRS-073 Cardiac 12-lipoxygenase-induced Inflammation is Involved in Heart Failure(FRS15,Novel Molecular Mechanisms of Heart Failure 1 (M),Featured Research Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• Bone Marrow Cell Transplantation into the Heart is Not a Crucial Factor of Ventricular Fibrillation in a Rat Doxorubicin-Induced Cardiomyopathy Model
• OE-293 Mechanisms Underlying Coronary Vasopsasm at Distal Arterial Segments of Sirolimus-Eluting Stent Implantation in a Porcine Model(OE50,Coronary Circulation/Chronic Coronary Disease (Basic/Clinical) (IHD),Oral Presentation (English),The 73rd Annual Sc
• OE-059 Cholesterol-lowering Therapy with the Cholesterol Absorption Inhibitor Ezetimibe Inhibits Plaque Destabilization and Rupture in the Brachiocephalic Arteries of ApoE-deficient Mice(OE10,Atherosclerosis, Basic 1 (IHD),Oral Presentation (English),The
• Essential Role of Angiotensin II Type 1a Receptors in the Host Vascular Wall, but Not the Bone Marrow, in the Pathogenesis of Angiotensin II-Induced Atherosclerosis
• PJ-375 Nanoparticle-Mediated Intracellular Delivery of Imatinib, a PDGF-Receptor Tyrosine Kinase Inhibitor, in Porcine Coronary Arteries from Nanoparticle-Eluting Stent Attenuates Neointimal Formation(Restenosis basic/clinical(04)(IHD),Poster Session(Japa
• PJ-170 Blockade of NF-κB by Nano-DDS of NF-κB decoy to the lung ameliorates monocrotaline-induced Pulmonary Arterial Hypertension(Pulmonary circulation(03)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• OJ-222 Nanoparticle-Mediated Delivery of HMG-CoA Reductase Inhibitor (statin)from Nanoparticle-Eluting Stent Attenuates In-Stent Stenosis in Porcine Coronary Arteries in Vivo(Restenosis basic / clinical(02)(IHD),Oral Presentation (Japanese),The 72nd Annua
• OE-188 Monocyte-targeting Nanoparticle-based Delivery of Pioglitazone Inhibits Plaque Rupture in the Brachiocephalic Arteries of Apolipoprotein-E Deficient Mice(Atherosclerosis, basic(01)(IHD),Oral Presentation(English),The 72nd Annual Scientific Meeting
• FRS-029 Monocyte-Targeting Nanoparticle-Based Delivery of Anti-Monocyte Chemoattractant Protein-1 Gene Inhibits Plaque Rupture of Brachiocephalic Arteries in Apolipoprotein-E Deficient Mice(Novel Mechanisms in Atherosclerosis (IHD),Featured Research Sessi
• 4 Single Intratracheal Administration of Bioabsorbable Nanoparticle Incorporated with Statin Ameliorates Monocrotaline-induced Pulmonary Arterial Hypertension and Survival(Young Investigator's Award for International Students Finalists Lecture (YIA Intern
• PJ-326 Intracellular Delivery of Imatinib (PDGF Receptor Tyrosine Kinase Inhibitor) with Bioabsorbable Polymeric Nanoparticle Technology Effectively Suppresses Vein Graft Neointima Formation(Cardiovascular surgery/CABG-2, The 71st Annual Scientific Meetin
• PE-334 Parallel Increases in LV End-systolic Elastance and Arterial Elastance in Elderly Japanese with Hypertension Make Apparent Systolic Function Normal(Echo/Doppler-12, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• PE-130 Blockade of Vascular Endothelial Cell Growth Factor by Catheter-Based Adenovirus-Mediated Gene Therapy Attenuates In-Stent Neointima Formation in Cynomolgus Monkeys(Atherosclerosis, basic-7, The 71st Annual Scientific Meeting of the Japanese Circul
• PE-037 An Essential Role of Angiotensin II Type 1 Receptor in Arterial Wall, Not in Bone Marrow, in Angiotensin II-Induced Atherosclerosis(Atherosclerosis, basic-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• OJ-177 A Novel Nanotechnology-Based Strategy for Therapeutic Neovascularization : Local Delivery of Statin with Biodegradable-Polymeric-Nanoparticle Improves Therapeutic Efficacy of Ischemic Neovascularization(Regeneration (angiogenesis / myocardial regen
• OJ-081 Sustained Intracellular Delivery of Nanoparticles in Porcine Coronary Arteries from a Bioabsorbable Polymeric Nanoparticle-Eluting Stent(Coronary revascularization, PCI-05, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• PJ-646 A Third-generation Long-acting Dihydropyridine Calcium Channel Blocker, Azelnidipine Inhibits Migration/Proliferation of Vascular Smooth Muscle Cells through Suppression of MCP-1 Release(Cardiovascular pharmacology, basic/clinical-5 (H) PJ109,Poste
• OJ-189 Feasibility of Biodegradable Polymeric Nanoparticle Technology for Intracellular Drug Delivery as a Novel Treatment of Vein Graft Disease(Cardiovascular surgery/CABG-1 (IHD) OJ32,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific M
• Angiotensin-Converting Enzyme Activity is Involved in the Mechanism of Increased Endogenous Nitric Oxide Synthase Inhibitor in Patients With Type 2 Diabetes Mellitus
• Angiotensin-Converting Enzyme Activity is Involved in the Mechanism of Increased Endogenous Nitric Oxide Synthase Inhibitor in Type II Diabetes Mellitus
• Renin-Angiotensin System is Involved in the Mechanism of Increased Serum Asymmetric Dimethylarginine in Essential Hypertension
• Stromal Cell-Derived Factor-1α Gene Transfer Induces Therapeutic Angiogenesis by Recruiting Endothelial Progenitor Cells via the VEGF/eNOS Pathway
• Vitamin C Improves Attenuated Angiotensin II-Induced Endothelium-Dependent Vasodilation in Human Forearm Vessels
• FRS-117 An Initial Result of 2-Year Follow Up of 17 Clinical Cases With an NF-κ B Decoy Transfection at the Coronary Stenting(Coronary Revascularization (clinical) 2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• Initial Clinical Cases of the Use of a NF-κB Decoy at the Site of Coronary Stenting for the Prevention of Restenosis
• Engineering of poly(DL-lactic-co-glycolic acid) nanocomposite particles for dry powder inhalation dosage forms of insulin with the spray-fluidized bed granulating system
• Identification of a novel gene involved in the pathogenesis of cardiac hypertrophy in rats
• HMG-CoA Reductase Inhibitor Limits Angiotensin II-Induced Progression and Destabilization of Established Atherosclerosis in ApoE-Knockout Mice through Its Cholesterol-Lowering Independent Actions
• Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Limits Progression and Destabilization of Established Atherosclerosis in Apolipoprotein E-Knockout Mice
• Anti-monocyte chemoattractant protein-1 gene therapy inhibits neointimal hyperplasia after balloon angioplasty in rats and monkeys
• Blockade of Vascular Endothelial Growth Factor Signals by sFLT-1 Gene Transer Attenuates Neointimal Hyperplasia after Perivascular Injury in Mice
• Monocyte Chemoattractant Protein-1 is Vital in Angiotensin II-induced Progression and Destabilization of Established Atherosclerosis in Apolipoprotein E-Knockout Mice
• Anti-inflammation Strategy Via Local Gene Transfer with Geneeluting Stents Attenuates in-stent Restenosis in Hypercholesterolemic Rabbits and Monkeys(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 16 (IHD), The 69th Annual Scientific Mee
• PE-318 Vascular Endothelial Growth Factor is an Essential Mediator in the Development of Angiotensin II-induced Arteriosclerosis(Atherosclerosis, Basic 4 (IHD) : PE54)(Poster Session (English))
• OE-123 Blockade or Abrogation of Angiotensin II AT1 Receptor Suppressed Accelerated Diabetic Atherosclerosis in Streptozotosin-Induced Diabetic Apolipoprotein E-Deficient Mice(Atherosclerosis, Basic 1 (IHD) : OE14)(Oral Presentation (English))
• OE-120 Cholesterol-lowering independent regression and stabilization of atherosclerotic lesions by pravastatin in nonhuman primates(Atherosclerosis, Basic 1 (IHD) : OE14)(Oral Presentation (English))
• Upregulation of Monocyte Chemoattractant Protein (MCP)-1 Receptor in Circulating Monocytes Contributes to Angiotensin II : Induced Arteriosclerosis/Atherosclerosis
• Soluble FLt-1 Gene Transfer Attenuates Neointimal Hyperplasia after Perivascular Injury in Apoliporotein-E Knockout Mice
• Enhanced Expression of MCP-1 Receptor in Circulating Monocytes in Hypertensive Patients through Angiotensin II Type 1 Receptor
• OE-064 Critical Role of Angiotensin II AT1 Signals in Vascular Senescence in Atherogenesis(Atherosclerosis, basic-1 (H) OE11,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
• Angiotensin II AT1 Receptor-Mediated Enhanced RAGE Signals are Responsible for the Mechanism of Accerelated Atherosclerosis by Diabetes Mellitus(Atherosclerosis, Basic 10 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• OE-183 A New Drug Delivery System Using Fibronectin-VEGF Fusion is More Effective and Harmless than VEGF Alone for the Therapeutic Neovascularization(Growth factor/Cytokine(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japane
• cAMP-Response Element-Binding Protein Mediates Prostaglandin F_2α-Induced Hypertrophy of Vascular Smooth Muscle Cells
• Suppression of Neointimal Formation in a Canine Model of Vein Graft Disease by Adenovirus-Mediated Anti Monocyte Chemoattractant Protein-1 Gene Therapy(Gene Therapy 3 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Coronary Vascular K+ATP Channels Contribute to the Maintenance of Myocardial Perfusion in Dogs With Pacing-Induced Heart Failure
• Gene Therapy Targeting Monocyte Chemoattractant Protein-1 For Vascular Disease
• Blockade of Vascular Endothelial Growth Factor Attenuates Experimental Restenosis after Intraluminal Injury
• 2 Stent-Based Local Delivery of Nuclear Factor-k B Decoy Attenuates In-Stent Restenosis in Hypercholesterolemic Rabbits(Young Investigator's Award Finalists Lecture (YIA),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
• A Third-generation Long-acting Dihydropyridine Calcium Channel Blocker, Azelnidipine Attenuates Stent-associated Neointimal Formation in Hypercholesterolemic Non-human Primates (Restenosis after Angioplasty, Basic/Clinical 6 (IHD), The 69th Annual Scienti
• A Third-generation Long-acting Dihydropyridine Calcium Channel Blocker, Azelnidipine Attenuates Atherosclerosis Through Antioxidant Actions in Hypercholesterolemic Mice and Monkeys(Atherosclerosis, Basic 5 (IHD), The 69th Annual Scientific Meeting of the
• Catheter-based Adenovirus-mediated Local Gene Transfer of Anti-inflammation Factor Attenuates In-stent Neointimal Formation in Non-human Primates(Restenosis after Angioplasty, Basic/Clinical 5 (IHD), The 69th Annual Scientific Meeting of the Japanese Circ
• OE-121 Absence of monocyte chemoattractant protein-1 receptor CCR2 on monocytes supresses angiotensin II-induced progression of atherosclerosis in ApoE-deficient mice(Atherosclerosis, Basic 1 (IHD) : OE14)(Oral Presentation (English))
• FRS-166 Stent-based delivery of nuclear factor-κB(NF-κB) attenuates in-stent restenosis in hypercholesterolemic rabbits(Coronary Heart Disease : Basic Science (IHD) : FRS20)(Featured Research Session (English))
• Anti-Monocyte Chemoattractant Protein-1 Therapy Reduces Experimental In-Stent Restenosis in Hypercholesterolemic Rabbits
• A gene therapy targeting early growth response factor-1 by "decoy" strategy inhibits neointinal hyperplasia in hypercholesterolemic rabbits
• Pioglitazone prevents Coronary Arteriosclerosis through inhibition of inflammation by downregulation of monocyte CCR2 in Rat
• 3 Development of a Novel Bioabsorbable Polymeric Nanoparticle-Eluting Stent by an Actively-Controlled Multilayer Coating Technology(What is New Nano-Technology in the Cardio-vascular Medicine?, The 71st Annual Scientific Meeting of the Japanese Circulatio
• Clinical Importance of Endothelial Function in Arteriosclerosis and Ischemic Heart Disease
• The Role of VEGF System in Restenosis and Arteriosclerosis
• 3 Anti-Monocyte Chemoattractant Protein-1 (MCP-1) Therapy Against Restenosis(Plenary Session 4 (PL4) (IHD) : Restenosis after PCI 2003 : New Therapies for the Next Generation)(Special Program)
• Bone Marrow-derived Monocyte Chemoattractant Protei-1 Receptor CCR2 is Critical in Angiotensin II-induced Vascular Remodeling and Atherosclerotic Process(Recent Advance in the Role of Renin-Angiotensin-Aldosterone System in Atherosclerotic Vascular Diseas
• 4 Nanoparticle-mediated Endothelial Cell-selective Delivery of Pitavastatin Induces Therapeutic Neovascularization(Latest Development of Nanotechnology Revolutionizes Treatments of Cardiovascular Diseases,Topic 3 (TP-3) (H),The 73rd Annual Scientific Meet
• Local Gene Transfer via Gene-Eluting Stents for Prevention of Restenosis : An Anti-inflammation Strategy for Next-Generation Intravascular Therapy(New Technologies in the Drug-Eluting Stent Era, The 69th Annual Scientific Meeting of the Japanese Circulati
• Novel anti-MCP-1 gene therapy against restenosis and atherosclerosis
• Anti-monocyte chemoattractant protein-1 gene therapy protects against experimental autoimmune myocarditis
• Ultrastructural and Immunohistochemical Studies on Uptake and Distribution of FITC-Conjugated PLGA Nanoparticles Administered Intratracheally in Rats

もっと見る 閉じる

スポンサーリンク